The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer—Further observations from the IMPACT solid study-Reference-Cited by-同舟云学术

The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer—Further observations from the IMPACT solid study

Published:2016-02 Issue: Volume:25 Page:27-33
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Mäenpää Johanna,Varthalitis Ioannis,Erdkamp Frans,Trojan Andreas,Krzemieniecki Krzysztof,Lindman Henrik,Bendall Kate,Vogl Florian D.,Verma Shailendra

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference33 articles.

1. Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trials;Dale;J Natl Compr Cancer Netw,2003

2. Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study;Pettengell;Support Care Cancer,2008

3. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients;Kuderer;Cancer,2006

4. Mortality, length of stay, and health care costs of febrile neutropenia-related hospitalizations among patients with breast cancer in the United States;Pathak;Support Care Cancer,2015

5. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B;Budman;J Natl Cancer Inst,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Use of Granulocyte-Colony Stimulating Factor in Patients with Breast Cancer from Alberta, Canada;Cancers;2022-12-15

2. Impact of granulocyte-colony stimulating factor on docetaxel-induced febrile neutropenia in patients with breast cancer;Journal of Oncology Pharmacy Practice;2021-08-03

3. Dose-dense paclitaxel plus carboplatin vs. epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancer;Chinese Journal of Cancer Research;2020

4. Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer;Acta Oncologica;2019-10-04

5. Patterns of Use of Docetaxel-Containing Adjuvant Chemotherapy Among Chinese Patients with Operable Breast Cancer: A Multicenter Observational Study;Advances in Therapy;2018-12-03